Announced Mon, 25 May · 15:23 IST

Magenta Lifecare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/05/2026 ,inter alia, to consider and approve Pursuant to Regulation 29(1) ....

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-5.0%1-day move
₹10.04
prior close
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-5.0-1.4-6.3-9.4
Up moveDown movePending
AI summary

The company has informed BSE that its Board of Directors meeting is scheduled for 28th May 2026 at 4:00 PM at the registered office in Vadodara, Gujarat. The agenda includes consideration and approval of the audited financial results for the half year and full year ended 31st March 2026, along with the Auditor's Report. The meeting is being held pursuant to SEBI LODR Regulation 29(1). The intimation is signed by Divyesh Vipinchandra Modi, Managing Director, and was submitted on 25th May 2026.

Likely market impact

This is a routine pre-result intimation filing. The actual financial results and any notable items such as auditor opinions, exceptional items, or changes in financial position will be disclosed after the Board meeting. Shareholders should await the official results announcement for meaningful analysis.